Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Declines By 13.1%

CV Sciences, Inc. (OTCMKTS:CVSI) saw a large drop in short interest during the month of January. As of January 30th, there was short interest totaling 12,867 shares, a drop of 13.1% from the January 15th total of 14,803 shares. Based on an average daily volume of 823,759 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are sold short. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 823,759 shares, the short-interest ratio is presently 0.0 days.

CV Sciences Stock Up 20.3%

Shares of CVSI stock opened at $0.05 on Tuesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.21 and a current ratio of 1.07. CV Sciences has a twelve month low of $0.02 and a twelve month high of $0.10. The business has a fifty day simple moving average of $0.05 and a 200 day simple moving average of $0.04.

About CV Sciences

CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.